Past infection with covid-19 does not necessarily confer protection against future infection, especially when it comes to the delta and omicron variants, researchers have warned.
Wendy Barclay, head of infectious disease at Imperial College London, told an event organised by the Zoe study group1 on 3 February, “Each variant is different from the starting virus, but it’s not necessarily a linear difference. If you can picture in three dimensional space the original Wuhan one sitting in the middle—some of the other variants have sort of gone out from Wuhan but in different directions. The two that are most different from each other are delta and omicron.”
She said people who think their past infection will give them good protection against future variants may be mistaken, and that this is a powerful reason to get vaccinated. “You’re actually better off being vaccinated, even if you get infected on top of that vaccine, as we can see that it broadens out the immune response and gives you potentially better protection against all the other variants that are going to come a little later,” Barclay said.
BA.2
Regarding the omicron variant sub-lineage BA.2, which is now spreading in the UK with more than 1000 confirmed cases reported in England as of 31 January 2022,2 Barclay explained that there are three versions of omicron—BA.1 (the version of omicron that has spread widely around the world), BA.2, and BA.3.
Early data suggested that BA.2 has a slight advantage over BA.1, despite there not seeming to be a huge difference between them, said Barclay. She said both have a “double whammy ability” with a lot of changes in the spike protein, meaning that the antibodies the population has made against vaccines or previous infection are not able to “see the virus very well.” BA.2 may also have some other attributes that make it better at transmitting, which is how it is starting to displace BA.1 in countries such as Denmark.
She suggested that as the “number of slight changes in BA.2 is somewhat less,” BA.1 may have accumulated so many changes that it has “compromised to a degree its own fitness, whereas BA.2 has struck a better balance with the escape from antibodies, while maintaining good transmissibility.”
The UK Health Security Agency has warned that BA.2 has an “increased growth rate” compared with BA.1, and that those with BA.2 are more likely to infect household contacts.
Variant vaccines
Looking at the future of the pandemic and protection against SARS-CoV-2, Barclay discussed the importance of developing vaccines that can protect against many different variants. She said that while many vaccine manufacturers, especially those using mRNA technology, have marketed themselves on the idea that their platform can be rapidly adapted to fit new variants, there is little evidence that this is happening.
“I know that they’ve developed vaccines against beta, but beta has been and gone and we’re now on omicron. I don’t think we’re going to have an omicron vaccine, for the UK anyway, until omicron has been and gone,” Barclay said.
She has suggested that multivalent vaccines designed to work against several variants at once may be the future. Barclay noted, however, that this was a big challenge, and one that has still not been overcome for the likes of influenza. “There are some great ideas that are being tested at the moment, but in the short term I don’t see that happening.”

News
Can our mitochondria help to beat long Covid?
At Cambridge University’s MRC Mitochondrial Biology Unit, Michal Minczuk is one of a growing number of scientists around the world aiming to find new ways of improving mitochondrial health. This line of research could help [...]
Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break [...]
Graphene Nanosensor Detects Biomarkers Through Tears
In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor. The ability to detect [...]
How Nanotechnology Can Make a Splash in Aquaculture
Selenium (Se) is an essential element found in aquatic feeds that promotes the proper development, wellbeing, and fitness of marine animals. Selenium can be transformed into nanomaterials that are more easily accessible, absorbed, and consumed by [...]
Super-Resolution Imaging Method For Multiple Fluorescence Microscopy Applications
In an article recently published in the journal Nanotechnology, researchers employed a single particle imaging method for fluorescence excitation with moderate intensity to achieve spatial resolution. Here, the semiconductor nanocrystals were accessed, whose emission lifetimes [...]
Trials to begin on new SA COVID-19 vaccine
A new COVID-19 vaccine developed in South Australia and administered with a needle-free device is to begin human trials. Designed by University of Adelaide researchers the DNA vaccine also targets the Omicron variant of [...]
Towards Carbon Clean Manufacturing with Eco-Friendly Nano-Lubricants
Grinding is an essential manufacturing process, yet the heat due to friction associated with the process causes damage to the part being processed. Lubrication is used to reduce friction; however, traditional petroleum-based lubricants can [...]
Researchers develop hybrid sensor that could help diagnose cancer
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today, the device can identify gases and [...]
Scientists Develop ‘Nanomachines’ That Can Penetrate And Kill Cancer Cells
Researchers have made a scientific breakthrough with the development of ‘nanomachines’ that can kill cancerous cells. The research team headed by Dr Youngdo Jeong from the Center for Advanced Biomolecular Recognition at the Korea Institute of Science and Technology (KIST) has engineered [...]
Green Method to Make Nanoparticles and Ultrafine Powder
A novel freeze-dissolving approach has been devised that offers greater efficiency and sustainability compared to the classic freeze-drying process to make superfine powder or nanoparticles. In the research published in the journal ACS Sustainable Chemistry & Engineering, sphere-shaped [...]
Participants wanted for study on the regulation of what future AI-driven nanomedicines should look like
Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical [...]
Could gold nanoparticles help treat cancer?
Gold nanoparticles are minuscule particles made of gold. From drug and gene delivery to photothermal and photodynamic therapies to screening and diagnostic tests to radiation therapy, X-ray imaging and CT scans, these small particles [...]
Carbon Dots Target Nucleolus and Monitor in Real-Time
In an article recently published in the journal Applied Surface Science, the researchers synthesized green fluorescent carbon dots (G-CDs) from 3,5-diaminobenzoic acid and citric acid. The as-prepared G-CDs were used to target the nucleolus and [...]
Green Nanoformulation for Anti-Cancer and Antibacterial Functions
Doxorubicin (DOX) is a powerful anti-cancer medication, and efforts have been made to design nanostructures for delivering it to cancerous cells. The nanostructures increase the cytotoxic effects of DOX on cancerous cells, while reducing the negative effects [...]
New drug delivery system releases therapeutic cargo only when bacteria are present
A team of Brown University researchers has developed a new responsive material that is able to release encapsulated cargo only when pathogenic bacteria are present. The material could be used to make wound dressings [...]
Hairy Cell Leukemia Complicated by Severe COVID-19: A Case Study
Novel three-drug regimen used to manage life-threatening developments. In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone [...]